Improved Outcome of Antihypertensive Therapy Associated With ...

Analysis of the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) study and substudy published in the Nov. 17 issue of JAMA showed that improved outcome of antihypertensive therapy was associated with reduction in left ventricular hypertrophy (LVH) either by electrical criteria or echocardiography. The editorialist suggests that while we are awaiting the definitive study, it may be appropriate to evaluate LVH during antihypertensive therapy."